Further studies will be needed to determine the mechanism through which EGFR-PPARGC1A in cSCC regulate tumor formation, which may lead to a better understanding of the pathogenesis of cSCC, new diagnostic methods, and new targeted cancer therapies. This evidence concerns the gene EGFR and skin squamous cell carcinoma.